Get the Stockscreener App
0.3285
0.15%
-0.0008
Io Biotech Inc stock is traded at $0.3285, with a volume of 215.49K.
It is down -0.15% in the last 24 hours and down -55.51% over the past month.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
See More
Previous Close:
$0.3293
Open:
$0.318
24h Volume:
215.49K
Relative Volume:
0.02
Market Cap:
$23.61M
Revenue:
-
Net Income/Loss:
$-86.08M
P/E Ratio:
-0.1523
EPS:
-2.1574
Net Cash Flow:
$-72.06M
1W Performance:
+58.38%
1M Performance:
-55.51%
6M Performance:
-86.30%
1Y Performance:
-65.39%
1-Day Range:
$0.3134
$0.334
1-Week Range:
$0.2302
$0.5792
52-Week Range:
$0.2053
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Name
Io Biotech Inc
Sector
Industry
Phone
(457) 070-2980
Address
OLE MAALOES VEH 3, COPENHAGEN
Compare IOBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.3281 | 23.69M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.24 | 120.31B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.19 | 81.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 53.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
352.30 | 46.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
345.88 | 37.20B | 4.98B | 69.59M | 525.67M | 0.5197 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-30-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-30-25 | Downgrade | TD Cowen | Buy → Hold |
Io Biotech Inc Stock (IOBT) Latest News
Is IO Biotech Inc. a top pick in the sectorWeekly Trend Recap & Daily Volume Surge Signals - mfd.ru
Piper downgrades IO Biotech amid strategic alternatives evaluation - Yahoo Finance
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review By Investing.com - Investing.com South Africa
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review - Investing.com
Piper Sandler Downgrades IO Biotech (IOBT) to Neutral, Lowers Pr - GuruFocus
IO Biotech stock rating downgraded by Piper Sandler amid strategic review - Investing.com Canada
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - MSN
Aug Decliners: Is IO Biotech Inc a potential multi baggerMarket Growth Report & Entry and Exit Point Strategies - baoquankhu1.vn
IOBT IO Biotech, Inc. (NASDAQ) $0.47 on 22 Jan 2026: active intraday mover for traders - Meyka
IO Biotech’s Future Uncertain As Cylembio Cloud Remains - Citeline News & Insights
IO Biotech Begins Review Of Strategic Options As Cash Runway Narrows - Nasdaq
IO Biotech weighs strategic options months after FDA advises against melanoma vaccine filing - European Biotechnology Magazine
IO Biotech admits defeat | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Listed Danish biotech company fights for survival after FDA rejection and failed capital raising - medwatch.com
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq
IO Biotech stock plummets after company explores strategic alternatives By Investing.com - Investing.com Nigeria
IO Biotech stock plummets after company explores strategic alternatives - Investing.com
IO Biotech announces exploration of strategic alternatives - TipRanks
IO mulls more layoffs months after halving head count in wake of cancer vaccine setback - Fierce Biotech
IO Biotech Explores Strategic Alternatives Amid Cost-Cutting Plans - TipRanks
IO Biotech (IOBT) Explores Strategic Alternatives to Maximize Shareholder Value - Intellectia AI
IO Biotech, Inc. Announces Exploration of Strategic Alternatives - TradingView
IO Biotech to explore strategic alternatives - MSN
IO Biotech Announces Exploration of Strategic Alternatives - The Manila Times
IO Biotech Announces Exploration of Strategic Alternatives to Enhance Stockholder Value - Quiver Quantitative
Moderna cancer vaccine holds up; IO Biotech considers a sale - Yahoo Finance
Cancer vaccine developer weighs sale, merger or liquidation - Stock Titan
Market Review: How do insiders feel about SOPAWeekly Stock Report & Real-Time Stock Entry Alerts - baoquankhu1.vn
Market Trends: What is the long term forecast for IO Biotech Inc stockJuly 2025 Momentum & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Valuation Update: Can ALCY lead its sector in growthWeekly Trade Recap & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
IO Biotech receives Nasdaq notice for bid price noncompliance - MSN
Jefferies maintains IO Biotech Buy rating, $8 target on PFS hopes - MSN
IO Biotech Faces Existential Threats as Funding and Regulatory Woes Mount - AD HOC NEWS
Aug Shorts: Will IO Biotech Inc outperform tech stocksJuly 2025 Action & Verified Swing Trading Watchlists - baoquankhu1.vn
What margin trends mean for IO Biotech Inc. stockMarket Growth Report & Weekly Setup with High ROI Potential - Bộ Nội Vụ
Sectors Review: Will IO Biotech Inc outperform tech stocks2025 Big Picture & High Conviction Investment Ideas - baoquankhu1.vn
Hedge Fund Moves: Can IO Biotech Inc beat the S P 500GDP Growth & Proven Capital Preservation Tips - baoquankhu1.vn
Published on: 2026-01-10 21:43:17 - Улправда
Wall Street Zen Upgrades IO Biotech (NASDAQ:IOBT) to Hold - Defense World
Will IO Biotech Inc. stock attract ESG investors2025 Breakouts & Breakdowns & Community Consensus Picks - Улправда
Why IO Biotech Inc. stock could benefit from AI revolutionStop Loss & Reliable Trade Execution Plans - Улправда
Morgan Stanley downgrades IO Biotech stock to Underweight on cash concerns By Investing.com - Investing.com South Africa
Morgan Stanley downgrades IO Biotech stock to Underweight on cash concerns - Investing.com Nigeria
IO Biotech, Inc. (NASDAQ:IOBT) Given Average Rating of “Hold” by Analysts - Defense World
Will IO Biotech Inc. stock outperform international peers2026 world cup usa national team semifinals top scorers set piece tactics odds analysis breakdown - ulpravda.ru
How IO Biotech Inc. stock performs during Fed tightening cyclesVolatility Adjusted Trading & Grow Smarter With Pro-Level Research - bollywoodhelpline.com
Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Decreases By 29.2% - MarketBeat
IO Biotech (NASDAQ:IOBT) Stock Rating Lowered by Wall Street Zen - Defense World
Will IO Biotech Inc. stock reach all time highs in 2025Stock Surge & Accurate Intraday Trade Tips - Улправда
How IO Biotech Inc. stock benefits from strong dollarJuly 2025 Reactions & Smart Allocation Stock Tips - Улправда
Io Biotech Inc Stock (IOBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
2.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):